Stephan Grabbe
Expertise in
12
conditions

Stephan Grabbe

Mainz, RP, DE 
Expertise in
12
conditions
Mainz, RP, DE 

Overview

Stephan Grabbe practices practicing medicine in Mainz, Germany.

Mr. Grabbe is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma, Hidradenitis Suppurativa, Merkel Cell Carcinoma, and Bowen's Disease.

He is actively involved in clinical research, co-authoring 273 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Mainz, RP, Germany
Other Locations
Gutenberg, RP, Germany
Essen, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II, Open-label, Randomized-controlled Trial Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody Atezolizumab for the Treatment in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma
A Phase II, Open-label, Randomized-controlled Trial Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody Atezolizumab for the Treatment in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma
Enrollment Status: Completed
Publish Date: April 09, 2025
Intervention Type: Drug
Study Drugs: Vemurafenib, Cobimetinib, Atezolizumab
Study Phase: Phase 2
A Randomized, Controlled, Open-Label, Phase 2 Study of Cemiplimab as a Single Agent and in Combination With RP1 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
A Randomized, Controlled, Open-Label, Phase 2 Study of Cemiplimab as a Single Agent and in Combination With RP1 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: January 27, 2025
Intervention Type: Biological, Drug
Study Drugs: Cemiplimab, RP1
Study Phase: Phase 2
Biopsy- and Biology-driven Optimization of Targeted Therapy of Metastatic Melanoma in BRAF Inhibitor Non-pretreated and Pretreated Subjects With Advanced, Non-resectable (STAGE IIIC) or Metastatic (StAGE IV) BRAF Mutation-positive Melanoma
Biopsy- and Biology-driven Optimization of Targeted Therapy of Metastatic Melanoma in BRAF Inhibitor Non-pretreated and Pretreated Subjects With Advanced, Non-resectable (STAGE IIIC) or Metastatic (StAGE IV) BRAF Mutation-positive Melanoma
Enrollment Status: Terminated
Publish Date: October 14, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

273 Total Publications

Collagen turnover biomarkers as diagnostic, prognostic, and therapy monitoring indicators in gastric cancer.
Collagen turnover biomarkers as diagnostic, prognostic, and therapy monitoring indicators in gastric cancer.
Journal: Cancer biomarkers : section A of Disease markers
Published: August 21, 2026

Frequently Asked Questions about Stephan Grabbe

Is Stephan Grabbe a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Stephan Grabbe is classified as an Distinguished expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stephan Grabbe participate in research or clinical trials?

Yes. Stephan Grabbe has published 273 articles and abstracts on conditions like Melanoma. You can view a list of Stephan Grabbe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Grabbe's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 59 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile